Practical reading from Professor Paul Lee and the Lincolnshire Hip Clinic team — across hip replacement, Arthrosamid, ChondroFiller, PRP and the wider world of hip and groin pain.
Liquid Cartilage™ (ChondroFiller) is not funded by the NHS because the National Institute for Health and Care Excellence has not issued a technology appraisal, despite the device's CE marking; available privately in the UK, it uses an injectable collagen scaffold to repair focal hip cartilage defects in younger or more active patients not yet candidates for joint replacement.
Three hip injections work at different biological levels: cortisone suppresses inflammatory flares for weeks; hyaluronic acid supplements joint lubrication; ChondroFiller places a collagen scaffold that prompts cartilage regeneration over months.
ChondroFiller regenerates focal cartilage defects via a collagen scaffold that recruits the body's repair cells; Arthrosamid cushions advanced hip osteoarthritis by integrating permanently into the synovial lining.
Hip pain ranges from self-resolving muscle strain to emergency joint infection; true hip joint pain presents in the groin, front thigh, or deep buttock, providing the first diagnostic clue.
ChondroFiller injection is a collagen scaffold placed over hip cartilage defects that stimulates the body's own repair process over six to twelve months; early evidence shows 81% of patients achieved good or excellent functional improvement.
Full recovery from a liquid cartilage hip injection takes up to two years because the body's progenitor cells must colonise the collagen scaffold and mature into cartilage—a timeline determined by cellular biology, not by pain or early comfort.
Groin pain near the hip has three main sources — adductor tendons, hip flexor, and the joint — with different movement triggers and treatment pathways. Misattribution is common: soft-tissue problems are often managed as joint disease whilst progressive conditions such as femoroacetabular impingement are overlooked as strain.
Microfracture for hip cartilage lesions produces fibrocartilage—scar-like tissue that fails under the joint's shear forces, with survival below 60% at three years. AMIC places a collagen membrane over the defect to guide stem cells toward hyaline cartilage instead.
ChondroFiller, a collagen scaffold that recruits a patient's own progenitor cells, meaningfully delays hip replacement in patients with focal Grade III–IV cartilage damage but offers no benefit in those with Tönnis Grade 2–3 osteoarthritis.
Lincolnshire Hip Clinic
Led by Professor Paul Lee
Start with a free, non-medical discovery call with our team. We will tell you, honestly, which of our pathways — surgical or non-surgical — fits your situation. No GP referral, no pressure to proceed.
What we offer
